Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 157-160, March 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawk, B. O.
Right arrow Articles by Inkley, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawk, B. O.
Right arrow Articles by Inkley, J. J.

An Evaluation of the Bolen Test as a Screening Test for Malignancy*

Bray O. Hawk, George E. Thoma and John J. Inkley

(From the Departments of Surgery and Medicine, St. Louis University School of Medicine, St. Louis, Mo.)

We have screened 505 patients for malignancy by the Bolen test. There were 66 positive tests, of which 12 were substantiated by histologic evidence of malignant neoplasm, while 54 appear to be false positives. With one exception, all the false positive tests subsequently reverted to negative.

There were 14 histologically proved cancers in the entire group of 505 patients. Two of these tumors gave repeated negative reactions to the Bolen test.

We may conclude that a negative Bolen test does not exclude the diagnosis of cancer. Nor does a positive test necessarily indicate the presence of cancer. However, a positive test should be followed by intense diagnostic effort before the diagnosis of malignant neoplasm is abandoned.

* Aided in part by Grant CT 619 USPHS and by a grant from Missouri Division, American Cancer Society.

Received 8/ 2/50.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.